期刊文献+

右美托咪啶用于SICU镇静时血流动力学效应与年龄的关系 被引量:1

Effect of Dexmedetomidine in Short-term Sedation of Patients in SICU
原文传递
导出
摘要 目的:以心率(HR)、心指数(CI)、体循环阻力(SVR)作为效应指标,明确右美托咪啶(Dex)用于SICU镇静时年龄和血流动力学效应的关系。方法:选择2014年3月~7月间在我院SICU接受普胸或者普外科手术后需要短期镇静患者38例,各年龄段分布相对均匀。在病人术后Ramsay评分≤3分时给予右旋美托咪啶6.0μg/kg/h,连续静脉输注10 min后停药,应用脉搏指示连续心输出量监测技术(PICCO)记录用药前及用药后3 min、5min、8min、10min、15min、20 min、30min、45min、60min、90min、120min的11个时间点的HR、CI和SVR。结果:HR、CI和SVR的EMAX随着年龄的增加而增大,可以通过数学模型表示:E=[-exp(E_(max)+delE_(max)·LOG(AGE/50))]·C^r/(C^r+C_(50)~r)(P<0.05)。结论:右美托咪啶用于SICU镇静时,患者HR、CI和SVR的EMAX呈年龄依赖性变化。 Objective:To clarify the correlation between hemodynamic effects and ages when Dexmedetomidine(Dex) used in SICU patients,by taking hart rate(HR),cardiac indexes(CI),and systemic circulation resistance(SVR) as the indexes.Methods:A total of38 patients,who needed short term sedation after chest or general surgery admitted to SICU of Renji Affiliated Hospital of School of Medicine of Shanghai Jiaotong University from March to July 2014,were selected.The distribution of each age group was relatively uniform.All the patients were treated with continuous intravenous infusion of dexmedetomidine(6.0 μg/kg/h) for 10 minutes when their Ramsay scores were ≤ 3 points after operation.Then HR,CI and SVR at 3 min,5 min,8 min,10 min,15 min,20 min,30 min,45 min,60 min,90 min,120 min before and after treatment were measured by pulse index continuous cardiac output(PICCO) method.Results:The EMAX of HR,CI and SVR was enlarged along with the increasing of age,which could be showed by mathematical model:E=[-exp(E_(max)+delE_(max)·LOG(AGE/50))]·C^r/(C^r+C_(50)~r)(P〈0.05).Conclusion:The Emax of HR,CI and SVR of SICU patients Presents age dependent changes when dexmedetomidine is used for sedation.
出处 《现代生物医学进展》 CAS 2015年第36期7175-7179,共5页 Progress in Modern Biomedicine
基金 上海市科学技术委员会科技攻关计划项目(13142201002)
关键词 右美托咪啶 年龄 E_(max) C_(50) Dexmedetomidine Age E_(max) C_(50)
  • 相关文献

参考文献21

  • 1Gao S, Wang Y, Zhao J, et al. Effects of dexmedetomidine pretreatment on heme oxygenase-I expression and oxidative stress during one-lung ventilation [J]. Int J Clin Exp Pathol, 2015, 8 (3): 3144-3149. 被引量:1
  • 2Volkov PA, Churadze BT, Sevalkin SA, et al. Dexmedetomidine as a part of analgesic component of general anesthesia for laparoscopic operations[J]. Anesteziol Raanimatol, 2015, 60(1): 4-8. 被引量:1
  • 3Sokhal N, Rath GP, Chaturvedi A, et al. Anaesthesia for awake craniotomy: A retrospective study of 54 cases [J]. Indian J Anacsth, 2015, 59(5): 300-305. 被引量:1
  • 4Kim HS, Byon HJ, Kim JE, et al. Appropriate dose of dexmedetomidine for the prevention of emergence agitation after desflurane anesthesia for tonsillectomy or adenoidectomy in children: up and down sequential allocation[J]. BMC Anesthesiol, 2015, 15:79. 被引量:1
  • 5Sanders RD, Giombini M, Ma D, et al. Dexmedetomidine Exerts Dose-Dependent Age-Independent Antinociception but Age- Dependent Hypnosis in Fischer Rats [J]. Anesth Analg, 2005, 100(5): 1295-1302. 被引量:1
  • 6Dyck JB, Maze M, Haack C, et al. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers[J]. Anesthesiology, 1993, 78:821-828. 被引量:1
  • 7Cox EH, Veyrat-Follet C, Beal SL, et al. A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic effect of ondansetron[J]. J Pharmacokinet Biopharm, 1999, 27(6): 625-644. 被引量:1
  • 8Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil:I. Model development[J]. Anesthesiology, 1997, 86( 1 ): 10-23. 被引量:1
  • 9Hu P, Chen J, Liu D, et al. Development of population pharmacokinetics model of icotinib with non-linear absorption characters in healthy Chinese volunteers to assess the CYP2C19 polymorphism and food-intake effect[J]. Eur J Clin Pharmacol, 2015, 71(7): 843-850. 被引量:1
  • 10Matsunaga N, Suzuki K, Nakanishi T, et al. Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytcs: effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide[J]. Drug Metab Pharmacokinet, 2015, 30(2): 142-148. 被引量:1

二级参考文献7

共引文献3

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部